Expected earnings - Contineum Therapeutics Inc.
Source: US Earnings Reports
Contineum Therapeutics Inc. (CTNM) is expected to report $-0.5 for Q4 2025
Contineum Therapeutics Inc.
NASDAQ: CTNM
CTNM Trading
-3.57% G/L:
$13.355 Last:
52,461 Volume:
$13.80 Open:
CTNM Latest News
March 05, 2026 04:05:00 pm
Contineum Therapeutics Reports Fourth-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones
March 03, 2026 04:05:00 pm
Contineum Therapeutics to Present at the 2026 Leerink Partners Global Healthcare Conference
CTNM Stock Data
$575,338,822
32,401,621
2.76%
10
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
